Deciphera Pharmaceuticals LLC
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $16.2600
- Today's High:
- $17.5400
- Open Price:
- $16.6800
- 52W Low:
- $6.51
- 52W High:
- $20.88
- Prev. Close:
- $16.8300
- Volume:
- 504445
Company Statistics
- Market Cap.:
- $1.112 billion
- Book Value:
- 6.06
- Revenue TTM:
- $0.109 billion
- Operating Margin TTM:
- -213.1%
- Gross Profit TTM:
- $-0.142 billion
- Gross Profit TTM:
- $-0.142 billion
- Profit Margin:
- -236.6%
- Return on Assets TTM:
- -27.8%
- Return on Equity TTM:
- -60.6%
Company Profile
Deciphera Pharmaceuticals LLC had its IPO on 2017-09-28 under the ticker symbol DCPH.
The company operates in the LIFE SCIENCES sector and PHARMACEUTICAL PREPARATIONS industry. Deciphera Pharmaceuticals LLC has a staff strength of 0 employees.
Stock update
Shares of Deciphera Pharmaceuticals LLC opened at $16.68 at the start of the last trading session i.e. 2022-11-02.
The stocks traded within a range of $16.26 - $17.54, and closed at $16.64.
This is a -1.13% slip from the previous day's closing price.
A total volume of 504,445 shares were traded at the close of the day’s session.
In the last one week, shares of Deciphera Pharmaceuticals LLC have slipped by -2.12%.
Deciphera Pharmaceuticals LLC's Key Ratios
Deciphera Pharmaceuticals LLC has a market cap of $1.112 billion, indicating a price to book ratio of 2.853 and a price to sales ratio of 10.19.
In the last 12-months Deciphera Pharmaceuticals LLC’s revenue was $0.109 billion with a gross profit of $-0.142 billion and an EBITDA of $-0.229 billion. The EBITDA ratio measures Deciphera Pharmaceuticals LLC's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Deciphera Pharmaceuticals LLC’s operating margin was -213.1% while its return on assets stood at -27.8% with a return of equity of -60.6%.
In Q2, Deciphera Pharmaceuticals LLC’s quarterly earnings growth was a positive 0% while revenue growth was a positive 37.8%.
Deciphera Pharmaceuticals LLC’s PE and PEG Ratio
- Forward PE
- -
- Trailing PE
- -
- PEG
- None
Its diluted EPS in the last 12-months stands at $-4.898 per share while it has a forward price to earnings multiple of - and a PEG multiple of None. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Deciphera Pharmaceuticals LLC’s profitability.
Deciphera Pharmaceuticals LLC stock is trading at a EV to sales ratio of 7.35 and a EV to EBITDA ratio of -3.139. Its price to sales ratio in the trailing 12-months stood at 10.19.
Deciphera Pharmaceuticals LLC stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $0.000 billion
- Total Liabilities
- $0.000 billion
- Operating Cash Flow
- $0.000 billion
- Capital Expenditure
- $0.000 billion
- Dividend Payout Ratio
- 0%
Deciphera Pharmaceuticals LLC ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.
Deciphera Pharmaceuticals LLC ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.
Deciphera Pharmaceuticals LLC’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.
In 1970, Deciphera Pharmaceuticals LLC's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.
Comparatively, Deciphera Pharmaceuticals LLC paid $0 billion in dividends in 1970.
Other key metrics
- Current Trading Price
- $16.64
- 52-Week High
- $20.88
- 52-Week Low
- $6.51
- Analyst Target Price
- $17.9
Deciphera Pharmaceuticals LLC stock is currently trading at $16.64 per share. It touched a 52-week high of $20.88 and a 52-week low of $20.88. Analysts tracking the stock have a 12-month average target price of $17.9.
Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Deciphera Pharmaceuticals LLC
Similar Industry Stocks (PHARMACEUTICAL PREPARATIONS)
Most Active
Top Gainers
Top Losers
About
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to improve the lives of cancer patients by addressing key drug resistance mechanisms that limit the rate and durability of response to existing cancer therapies. The company is headquartered in Waltham, Massachusetts.